GEVO Form 144: Notice to Sell 5,738 Shares on 08/05/2025
Form: Form 144 notice filed for GEVO (symbol provided in metadata).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form: Form 144 notice filed for GEVO (symbol provided in metadata). Planned sale: 5,738 Common Stock shares via Stifel Nicolaus & Company Inc., targeted approximate sale date 08/05/2025 on Nasdaq with an aggregate market value of $7,061.00. Shares outstanding reported: 239,562,995.
Acquisition details: the shares to be sold were recorded as Restricted Stock Units acquired from the issuer on 08/03/2025 (18,223 units) with payment dated 08/05/2025 and payment method: Cash. Prior activity: a separate sale by Leke Agiri on 06/03/2025 of 10,810 shares for $12,572.00.
Missing/limited fields: filer CIK, issuer name, contact and date-of-notice fields are not provided in the content. The filing includes the standard representation about material nonpublic information.
Insights
TL;DR: Routine small-volume insider sale sourced from recent RSU vesting; immaterial versus outstanding shares.
The Form 144 shows a planned sale of 5,738 GEVO common shares via Stifel on 08/05/2025 with an aggregate market value of $7,061 against 239,562,995 shares outstanding, representing roughly 0.0024% of outstanding stock. The shares were acquired as 18,223 RSUs on 08/03/2025 with cash payment recorded 08/05/2025. A prior sale of 10,810 shares on 06/03/2025 for $12,572 is disclosed. From a market-impact perspective, the sizes disclosed are immaterial to share supply; the filing lacks issuer and filer identification fields which reduces transparency for investors.
TL;DR: Filing documents compensation-related share acquisition and small subsequent sale; disclosure completeness is limited.
The record indicates the securities to be sold originated from RSUs granted by the issuer (acquired 08/03/2025, 18,223 units) and are scheduled for sale two days later. The filing contains the required representation regarding absence of undisclosed material information but omits key administrative items such as filer CIK and issuer name in the provided content. For governance and compliance review, the absence of complete filer/issuer identifiers in the document copy provided here is notable even though transaction specifics are present.
AI-generated analysis. How Rhea-AI works. Not financial advice.